In software testing, an edge case is a rare input at the boundary of a system's designed range. The system has limits; this input found them.
In organizational life, the phrase shifts. Calling something an "edge case" becomes a way of saying this person's situation does not warrant redesigning our process — technical language wrapped around what is, at bottom, a resource-allocation choice.
Automation widens this gap. When routine work gets cheap, exception handling grows relatively expensive. Organizations develop stronger incentives to describe governance choices as engineering facts, labeling situations "unsupported" when the real issue is that accommodation costs more than anyone wants to spend.
In healthcare prior authorization, HHS OIG found that Medicare Advantage organizations overturned 95% of appealed denials for skilled nursing admissions — but only 18% of denials were appealed. Those patients weren't rare inputs. They were people whose needs the system had chosen not to accommodate, in language that made a spending decision sound like a technical boundary.
Engineering edge case: A rare input the system wasn't designed for. Defined by technical boundaries.
Governance edge case: A situation the organization has chosen not to accommodate. Defined by what it's willing to spend.
The test: Is this case rare because of statistical distribution, or because of design choices about whose experience counts?
Where governance hides behind engineering:
- Accessibility: Researchers testing AI agents under assistive-technology conditions found task completion dropped from 78% to 28% when users relied on screen magnification. Those users aren't statistically rare — they're unaccommodated by mouse-dominant design assumptions.
- Algorithmic management: A feedback form exists, but the threshold for response is set by the system that created the problem. The appeal process is there; the question is whether it's designed to resolve complaints or absorb them.
- Automated denial: A 95% reversal rate on appeal suggests the initial denial reflects policy choices, not clinical judgment.

